Hisamitsu Pharmaceutical Co., Inc. (4530.T)
JPY 4437.0
(2.05%)
JPY 4437.0
(2.05%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 328.77 Billion JPY | 4.73% |
| 2022 | 313.91 Billion JPY | 3.65% |
| 2021 | 302.85 Billion JPY | 1.0% |
| 2020 | 299.86 Billion JPY | -2.45% |
| 2019 | 307.4 Billion JPY | 3.32% |
| 2018 | 297.51 Billion JPY | -0.8% |
| 2017 | 299.91 Billion JPY | 7.57% |
| 2016 | 278.82 Billion JPY | -2.15% |
| 2015 | 284.95 Billion JPY | -0.17% |
| 2014 | 285.44 Billion JPY | 13.34% |
| 2013 | 251.85 Billion JPY | 17.61% |
| 2012 | 214.14 Billion JPY | 11.05% |
| 2011 | 192.83 Billion JPY | -1.0% |
| 2010 | 194.78 Billion JPY | 0.64% |
| 2009 | 193.55 Billion JPY | 15.45% |
| 2008 | 167.64 Billion JPY | 11.95% |
| 2007 | 149.75 Billion JPY | 6.1% |
| 2006 | 141.14 Billion JPY | 3.34% |
| 2005 | 136.58 Billion JPY | 22.98% |
| 2004 | 111.06 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 338.83 Billion JPY | 3.06% |
| 2024 Q2 | 350.47 Billion JPY | 3.43% |
| 2023 FY | 328.77 Billion JPY | 4.73% |
| 2023 Q1 | 320.18 Billion JPY | 2.0% |
| 2023 Q2 | 344.3 Billion JPY | 7.53% |
| 2023 Q4 | 328.77 Billion JPY | -1.83% |
| 2023 Q3 | 334.9 Billion JPY | -2.73% |
| 2022 Q3 | 336.88 Billion JPY | 2.74% |
| 2022 Q4 | 313.91 Billion JPY | -6.82% |
| 2022 FY | 313.91 Billion JPY | 3.65% |
| 2022 Q1 | 307.76 Billion JPY | 1.62% |
| 2022 Q2 | 327.89 Billion JPY | 6.54% |
| 2021 Q3 | 303.99 Billion JPY | -1.81% |
| 2021 Q2 | 309.58 Billion JPY | 3.23% |
| 2021 Q1 | 299.9 Billion JPY | 0.01% |
| 2021 Q4 | 302.85 Billion JPY | -0.37% |
| 2021 FY | 302.85 Billion JPY | 1.0% |
| 2020 Q3 | 296.54 Billion JPY | -0.8% |
| 2020 FY | 299.86 Billion JPY | -2.45% |
| 2020 Q1 | 297.08 Billion JPY | -3.36% |
| 2020 Q4 | 299.86 Billion JPY | 1.12% |
| 2020 Q2 | 298.93 Billion JPY | 0.62% |
| 2019 Q3 | 307.98 Billion JPY | 3.79% |
| 2019 FY | 307.4 Billion JPY | 3.32% |
| 2019 Q1 | 290.12 Billion JPY | -2.48% |
| 2019 Q4 | 307.4 Billion JPY | -0.19% |
| 2019 Q2 | 296.73 Billion JPY | 2.28% |
| 2018 FY | 297.51 Billion JPY | -0.8% |
| 2018 Q1 | 293.52 Billion JPY | -2.13% |
| 2018 Q4 | 297.51 Billion JPY | -3.23% |
| 2018 Q3 | 307.43 Billion JPY | 0.84% |
| 2018 Q2 | 304.85 Billion JPY | 3.86% |
| 2017 Q3 | 298.75 Billion JPY | 3.24% |
| 2017 Q1 | 280.27 Billion JPY | 0.52% |
| 2017 FY | 299.91 Billion JPY | 7.57% |
| 2017 Q2 | 289.38 Billion JPY | 3.25% |
| 2017 Q4 | 299.91 Billion JPY | 0.39% |
| 2016 Q2 | 276.15 Billion JPY | -2.36% |
| 2016 Q4 | 278.82 Billion JPY | 2.41% |
| 2016 Q3 | 272.26 Billion JPY | -1.41% |
| 2016 Q1 | 282.83 Billion JPY | -0.74% |
| 2016 FY | 278.82 Billion JPY | -2.15% |
| 2015 Q4 | 284.95 Billion JPY | -2.63% |
| 2015 Q1 | 285.09 Billion JPY | -0.12% |
| 2015 Q2 | 294.29 Billion JPY | 3.23% |
| 2015 FY | 284.95 Billion JPY | -0.17% |
| 2015 Q3 | 292.65 Billion JPY | -0.56% |
| 2014 FY | 285.44 Billion JPY | 13.34% |
| 2014 Q1 | 251.58 Billion JPY | -0.11% |
| 2014 Q4 | 285.44 Billion JPY | 4.67% |
| 2014 Q3 | 272.7 Billion JPY | 2.16% |
| 2014 Q2 | 266.94 Billion JPY | 6.1% |
| 2013 Q3 | 247.91 Billion JPY | 1.18% |
| 2013 Q4 | 251.85 Billion JPY | 1.59% |
| 2013 FY | 251.85 Billion JPY | 17.61% |
| 2013 Q1 | 226.06 Billion JPY | 5.57% |
| 2013 Q2 | 245.02 Billion JPY | 8.38% |
| 2012 FY | 214.14 Billion JPY | 11.05% |
| 2012 Q1 | 197.8 Billion JPY | 2.57% |
| 2012 Q3 | 203.83 Billion JPY | 0.1% |
| 2012 Q4 | 214.14 Billion JPY | 5.05% |
| 2012 Q2 | 203.62 Billion JPY | 2.95% |
| 2011 Q1 | 191.87 Billion JPY | -1.49% |
| 2011 Q2 | 194.34 Billion JPY | 1.29% |
| 2011 Q4 | 192.83 Billion JPY | -0.59% |
| 2011 Q3 | 193.98 Billion JPY | -0.19% |
| 2011 FY | 192.83 Billion JPY | -1.0% |
| 2010 Q3 | 193.01 Billion JPY | -2.08% |
| 2010 Q2 | 197.12 Billion JPY | 3.05% |
| 2010 FY | 194.78 Billion JPY | 0.64% |
| 2010 Q1 | 191.29 Billion JPY | -1.17% |
| 2010 Q4 | 194.78 Billion JPY | 0.92% |
| 2009 Q2 | 198.09 Billion JPY | 21.62% |
| 2009 FY | 193.55 Billion JPY | 15.45% |
| 2009 Q4 | 193.55 Billion JPY | -5.09% |
| 2009 Q3 | 203.93 Billion JPY | 2.95% |
| 2009 Q1 | 162.88 Billion JPY | 0.0% |
| 2008 FY | 167.64 Billion JPY | 11.95% |
| 2007 FY | 149.75 Billion JPY | 6.1% |
| 2006 FY | 141.14 Billion JPY | 3.34% |
| 2005 FY | 136.58 Billion JPY | 22.98% |
| 2004 FY | 111.06 Billion JPY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 36.57 Billion JPY | -798.966% |
| Takeda Pharmaceutical Company Limited | 15108.79 Billion JPY | 97.824% |
| Sumitomo Pharma Co., Ltd. | 907.5 Billion JPY | 63.771% |
| Shionogi & Co., Ltd. | 1416.91 Billion JPY | 76.796% |
| Wakamoto Pharmaceutical Co.,Ltd. | 15.42 Billion JPY | -2032.014% |
| Nippon Shinyaku Co., Ltd. | 263.4 Billion JPY | -24.819% |
| Kaken Pharmaceutical Co., Ltd. | 171.62 Billion JPY | -91.57% |
| Eisai Co., Ltd. | 1393.79 Billion JPY | 76.411% |
| Morishita Jintan Co., Ltd. | 17.18 Billion JPY | -1813.397% |
| Mochida Pharmaceutical Co., Ltd. | 158.8 Billion JPY | -107.04% |
| Fuso Pharmaceutical Industries,Ltd. | 76.46 Billion JPY | -330.001% |
| Nippon Chemiphar Co., Ltd. | 49.54 Billion JPY | -563.557% |
| Tsumura & Co. | 428.25 Billion JPY | 23.228% |
| Kissei Pharmaceutical Co., Ltd. | 260.92 Billion JPY | -26.003% |
| Torii Pharmaceutical Co., Ltd. | 133.43 Billion JPY | -146.402% |
| Towa Pharmaceutical Co., Ltd. | 430.65 Billion JPY | 23.656% |
| Fuji Pharma Co., Ltd. | 85.33 Billion JPY | -285.294% |
| Zeria Pharmaceutical Co., Ltd. | 150.53 Billion JPY | -118.409% |
| KYORIN Holdings, Inc. | 177.67 Billion JPY | -85.041% |
| Taiko Pharmaceutical Co.,Ltd. | 15.04 Billion JPY | -2085.159% |
| Daito Pharmaceutical Co.,Ltd. | 77.7 Billion JPY | -323.095% |
| SymBio Pharmaceuticals Limited | 15.35 Billion JPY | -2041.598% |
| MedRx Co., Ltd | 2.05 Billion JPY | -15922.368% |
| Mizuho Medy Co.,Ltd. | 18.94 Billion JPY | -1635.135% |
| Solasia Pharma K.K. | 2.55 Billion JPY | -12793.294% |
| Modalis Therapeutics Corporation | 2.02 Billion JPY | -16128.587% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 93.31 Billion JPY | -252.344% |
| Sawai Group Holdings Co., Ltd. | 382.02 Billion JPY | 13.938% |
| Cyfuse Biomedical K.K. | 4.21 Billion JPY | -7700.567% |
| Toho Holdings Co., Ltd. | 773.42 Billion JPY | 57.491% |
| Koa Shoji Holdings Co.,Ltd. | 32 Billion JPY | -927.305% |